Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Chongqing Xishan Science and Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.19%.
SHSE:688576's ROC (Joel Greenblatt) % is ranked better than 51.08% of 836
companies
in the Medical Devices & Instruments industry
Industry Median: 4.94
vs SHSE:688576: 5.79
Chongqing Xishan Science and Technology Co (SHSE:688576) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co ROC (Joel Greenblatt) % Chart
Chongqing Xishan Science and Technology Co Annual Data
SHSE:688576 vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, Chongqing Xishan Science and Technology Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Xishan Science and Technology Co ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chongqing Xishan Science and Technology Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Chongqing Xishan Science and Technology Co's ROC (Joel Greenblatt) % falls into.
Chongqing Xishan Science and Technology Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 2.19% mean?
Chongqing Xishan Science and Technology Co (SHSE:688576) has a ROC (Joel Greenblatt) % of 2.19% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Chongqing Xishan Science and Technology Co and its competitors. This is 96% below median its historical median of 55.19. According to the industry distribution chart, Chongqing Xishan Science and Technology Co ranks #409 out of 836 companies in the Medical Devices & Instruments industry, placing it in the top 48.9%.
Is Chongqing Xishan Science and Technology Co's ROC (Joel Greenblatt) % too high?
Chongqing Xishan Science and Technology Co's current ROC (Joel Greenblatt) % of 2.19% is 96% below median its 10-year median of 55.19. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.94. Chongqing Xishan Science and Technology Co's value of 2.19% is 55.7% below this industry median. Based on the distribution chart, Chongqing Xishan Science and Technology Co ranks #409 out of 836 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Chongqing Xishan Science and Technology Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Xishan Science and Technology Co's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Chongqing Xishan Science and Technology Co ranks #409 out of 836 companies for ROC (Joel Greenblatt) %. This puts Chongqing Xishan Science and Technology Co in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 4.94. Chongqing Xishan Science and Technology Co's value of 2.19% is 55.7% below this benchmark. While the company's 10-year median is 55.19 vs. the industry median of 4.94, Chongqing Xishan Science and Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.94, based on 836 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chongqing Xishan Science and Technology Co's current ROC (Joel Greenblatt) % of 2.19% is 55.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Chongqing Xishan Science and Technology Co and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Xishan Science and Technology Co's current ROC (Joel Greenblatt) % is 2.19%, which is 96% below median its own 10-year median of 55.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Xishan Science and Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co (SHSE:688576) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥54.20, compared to a current price of ¥41.00 — trading 24.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is 2.19%, which is 96% below median its 10-year median of 55.19 and 55.7% below the Medical Devices & Instruments industry median of 4.94. Chongqing Xishan Science and Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Chongqing Xishan Science and Technology Co (SHSE:688576), the current ROC (Joel Greenblatt) % is 2.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Xishan Science and Technology Co (SHSE:688576) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co stock appears to be undervalued.
The current stock price of ¥41.00 is trading 24.4% below its estimated GF Value™ of ¥54.20.
GuruFocus considers Chongqing Xishan Science and Technology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688576:
ROC (Joel Greenblatt) %: 2.19% (96% below median its 10-year median of 55.19)
GF Value™: ¥54.20 vs. price of ¥41.00 (24.4% below fair value)
Industry Position: 55.7% below the Medical Devices & Instruments median (#409 of 836)
No single metric tells the full story. See the SHSE:688576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
90GF Score
Get the complete analysis for SHSE:688576
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688576 has been successfully added to your 
